Recent Announcements

PACE™ Reported to Heal Severe Burns without Surgery or Skin Grafting - U.S. Clinical Trial Expected, and European Distribution Partnerships Planned

Journal Article Shows PACE Improves Skin Flap Survival Rates; Supports IDE DFU Protocol.

Dr. Maria Siemionow, World Renowned Plastic Surgeon, Joins SANUWAVE's Scientific Advisory Board

SANUWAVE, Inc. Becomes a Public Company Through a Reverse Merger with a Subsidiary of Rub Music Enterprises, Inc. . . .SANUWAVE, Inc. Adds Southern Arizona VA Medical Center to its dermaPACE Investigational Device Exemption Clinical Trial for Diabetic Foot Ulcers. . . .

SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures.

SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body's normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.